Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epithelial-mesenchymal transition and drug resistance in breast cancer (Review)
Jing Huang, Hongzhong Li, Guosheng Ren
International Journal of Oncology (2015) Vol. 47, Iss. 3, pp. 840-848
Open Access | Times Cited: 140

Showing 1-25 of 140 citing articles:

Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
Bowen Du, Joong Sup Shim
Molecules (2016) Vol. 21, Iss. 7, pp. 965-965
Open Access | Times Cited: 701
Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence
Shian‐Ren Lin, Chia‐Hsiang Chang, Che‐Fang Hsu, et al.
British Journal of Pharmacology (2019) Vol. 177, Iss. 6, pp. 1409-1423
Open Access | Times Cited: 328
The basics of epithelial–mesenchymal transition (EMT): A study from a structure, dynamics, and functional perspective
Vishal Das, Sourya Bhattacharya, Channakeshavaiah Chikkaputtaiah, et al.
Journal of Cellular Physiology (2019) Vol. 234, Iss. 9, pp. 14535-14555
Closed Access | Times Cited: 227
Battling Chemoresistance in Cancer: Root Causes and Strategies to Uproot Them
Alisha Ramos, Samira Sadeghi, Hossein Tabatabaeian
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9451-9451
Open Access | Times Cited: 177
The mechanism of anticancer action and potential clinical use of kaempferol in the treatment of breast cancer
Xueni Wang, Yuting Yang, Yating An, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 117, pp. 109086-109086
Open Access | Times Cited: 168
A non-proliferative role of pyrimidine metabolism in cancer
Aarif Siddiqui, Paolo Ceppi
Molecular Metabolism (2020) Vol. 35, pp. 100962-100962
Open Access | Times Cited: 155
The Metabolic Mechanisms of Breast Cancer Metastasis
Lingling Wang, Shizhen Zhang, Xiaochen Wang
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 150
Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer Metastasis
Arpita Datta, Shuo Deng, Vennila Gopal, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1882-1882
Open Access | Times Cited: 122
Cancer-associated fibroblasts: Origin, function, imaging, and therapeutic targeting
Rahul Rimal, Prachi Desai, Rasika Daware, et al.
Advanced Drug Delivery Reviews (2022) Vol. 189, pp. 114504-114504
Open Access | Times Cited: 106
Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance
Hong Lin, Di Wang, Pinghan Wang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 84
Curcumin as an Enhancer of Therapeutic Efficiency of Chemotherapy Drugs in Breast Cancer
Reyhaneh Farghadani, Rakesh Naidu
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2144-2144
Open Access | Times Cited: 77
Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response
Nasim Ebrahimi, Mahdokht Sadat Manavi, Ferdos Faghihkhorasani, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 1, pp. 457-479
Closed Access | Times Cited: 27
14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling
Jing Luo, Jianfeng Yao, Xiaofei Deng, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 142
Hepatocyte Growth Factor, a Key Tumor-Promoting Factor in the Tumor Microenvironment
Benjamin Y. Owusu, Robert A. Galemmo, James W. Janetka, et al.
Cancers (2017) Vol. 9, Iss. 4, pp. 35-35
Open Access | Times Cited: 105
Long Non-Coding RNA HOTAIR in Breast Cancer Therapy
Monica Cantile, Maurizio Di Bonito, Margherita Cerrone, et al.
Cancers (2020) Vol. 12, Iss. 5, pp. 1197-1197
Open Access | Times Cited: 95
Polyphenolic Nutrients in Cancer Chemoprevention and Metastasis: Role of the Epithelial-to-Mesenchymal (EMT) Pathway
Haneen Amawi, Charles R. Ashby, Temesgen Samuel, et al.
Nutrients (2017) Vol. 9, Iss. 8, pp. 911-911
Open Access | Times Cited: 92
The Role of Hepatocyte Growth Factor (HGF) in Insulin Resistance and Diabetes
Alexandre G. Oliveira, Tiago Gomes Araújo, Bruno M. Carvalho, et al.
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 88
Circular RNAs in drug resistant tumors
Xin Hua, Yue Sun, Jing Chen, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 118, pp. 109233-109233
Open Access | Times Cited: 79
Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review
Heewa Shakib, Sadegh Rajabi, Mohammad Hossien Dehghan, et al.
Endocrine (2019) Vol. 66, Iss. 3, pp. 435-455
Closed Access | Times Cited: 79
Clinical impact of epithelial–mesenchymal transition for cancer therapy
Nobendu Mukerjee, Sagnik Nag, Bikramjit Bhattacharya, et al.
Clinical and Translational Discovery (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 11
Epithelial-Mesenchymal Transition (EMT) and Regulation of EMT Factors by Steroid Nuclear Receptors in Breast Cancer: A Review and in Silico Investigation
Ioannis A. Voutsadakis
Journal of Clinical Medicine (2016) Vol. 5, Iss. 1, pp. 11-11
Open Access | Times Cited: 85
Fisetin Inhibited Growth and Metastasis of Triple-Negative Breast Cancer by Reversing Epithelial-to-Mesenchymal Transition via PTEN/Akt/GSK3β Signal Pathway
Jie Li, Xia Gong, Rong Jiang, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 68
Resveratrol promotes sensitization to Doxorubicin by inhibiting epithelial‐mesenchymal transition and modulating SIRT1/β‐catenin signaling pathway in breast cancer
Xiaoxia Jin, Yingze Wei, Yushan Liu, et al.
Cancer Medicine (2019) Vol. 8, Iss. 3, pp. 1246-1257
Open Access | Times Cited: 67
Taxifolin inhibits breast cancer cells proliferation, migration and invasion by promoting mesenchymal to epithelial transition via β-catenin signaling
Jie Li, Lu Hu, Tao Zhou, et al.
Life Sciences (2019) Vol. 232, pp. 116617-116617
Closed Access | Times Cited: 66
Piperine: role in prevention and progression of cancer
Mariia Zadorozhna, Tiziana Tataranni, Domenica Mangieri
Molecular Biology Reports (2019) Vol. 46, Iss. 5, pp. 5617-5629
Closed Access | Times Cited: 66
Page 1 - Next Page

Scroll to top